Baxter International | BAX - Stock



Baxter International reported $2.17B in Stock for its fiscal quarter ending in March of 2025.


Stock Change Date
Abbott USD 6.95B 315M Jun/2025
AtriCure USD 76.34M 1.43M Jun/2025
Avanos Medical USD 142.7M 4.6M Jun/2025
Baxter International USD 2.17B 124M Mar/2025
Becton, Dickinson and Co. USD 3.95B 226M Jun/2025
Boston Scientific USD 2.87B 57M Mar/2025
Cooper Companies USD 881M 700K Jul/2025
Dexcom USD 570.7M 32.5M Jun/2025
Edwards Lifesciences USD 1.11B 27.2M Mar/2025
Fresenius EUR 2.59B 44M Jun/2025
Globus Medical USD 772.13M 108.53M Jun/2025
Halozyme Therapeutics USD 181.5M 16.64M Jun/2025
ICU Medical USD 616.47M 26.15M Jun/2025
Insulet USD 446.9M 6.1M Jun/2025
Integra LifeSciences USD 465.13M 19.71M Jun/2025
Intuitive Surgical USD 1.67B 113.4M Jun/2025
J&J USD 12.66B 215M Mar/2025
Laboratory Of America USD 508.1M 19.8M Jun/2025
Masimo USD 318.5M 17.3M Jun/2025
Medtronic USD 5.48B 134M Apr/2025
Merit Medical Systems USD 323.31M 5.37M Jun/2025
Quest Diagnostics USD 187M 2M Jun/2025
Stryker USD 5.29B 184M Jun/2025
Tandem Diabetes Care USD 142.57M 1.41M Jun/2025
Teleflex USD 693.69M 49.71M Jun/2025
Terumo JPY 300.99B 6.6B Jun/2025
Zimmer Biomet Holdings USD 2.45B 210M Jun/2025